The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Different outcomes of cardiologic safety of trastuzumab in adjuvant or metastatic setting in patients with breast cancer: A single institution experience.
G. Scandurra
No relevant relationships to disclose
R. A. Aiello
No relevant relationships to disclose
E. Taibi
No relevant relationships to disclose
M. V. SanĂ²
No relevant relationships to disclose
M. Ali
No relevant relationships to disclose
G. Fallica
No relevant relationships to disclose
M. Chiarenza
No relevant relationships to disclose
A. Mazzola
No relevant relationships to disclose
R. Di Marco
No relevant relationships to disclose
S. Clementi
No relevant relationships to disclose
M. G. V. Di Leo
No relevant relationships to disclose
E. Miano
No relevant relationships to disclose
M. Caruso
No relevant relationships to disclose